Related Experiment Videos
Selective amygdalo-hippocampectomy for temporal lobe epilepsy
1Department of Neurology, University Hospital, Zürich, Switzerland.
Epilepsia
|January 1, 1988
Summary
Selective amygdalo-hippocampectomy (AHE) offers a superior surgical option for treating medically intractable temporal lobe epilepsy with mediobasal limbic seizures. This approach leads to significant seizure reduction and improved cognitive function compared to standard temporal lobectomy.
Area of Science:
- Neurosurgery
- Epileptology
- Clinical Neurology
Background:
- Complex partial seizures can be classified into subtypes, with the mediobasal limbic subtype being clinically significant.
- Medically intractable temporal lobe epilepsy (TLE) often involves the amygdala and hippocampus.
- Conventional temporal lobectomy carries risks; selective amygdalo-hippocampectomy (AHE) was developed as an alternative.
Observation:
- 181 patients underwent microsurgical AHE for medically intractable mediobasal TLE.
- 52 patients without detectable preoperative lesions were studied using stereoelectroencephalography (SEEG) or foramen-ovale (FO) electrodes.
- Mean follow-up was 47 months.
Findings:
- 62% of patients became seizure-free, 10% had rare seizures, and 15% showed worthwhile improvement.
- 21% of patients discontinued antiepileptic drugs; others remained on medication.
- Good seizure outcomes correlated with the seizure-onset locus being within the resected area.
Implications:
- Selective AHE is a preferred surgical treatment for TLE with mediobasal limbic seizures over standard temporal lobectomy.
- Palliative AHE is a viable option when the seizure focus is near critical neocortex.
- Factors like hippocampal sclerosis, age, seizure duration, and EEG findings influence outcomes; cognitive function improved in successful cases.